Avance Clinical will be attending the World Orphan Drug Congress USA 2025 in Boston on April 23-24! As a full-service CRO specializing in agile and accelerated clinical development, we are committed to supporting biotechs advancing orphan drug research and rare disease treatments. With our Asia Advantage and GlobalReady models, we provide biotechs with faster regulatory pathways, diverse patient populations, and globally accepted data, ensuring seamless clinical trial execution from early to late-phase studies. 📅 Book a meeting with our team: https://lnkd.in/gyFFGTWr #WODCUSA #OrphanDrugs #RareDisease #ClinicalTrials #Biotech #CRO #AvanceClinical #ClinicalResearch #GlobalReady #AsiaAdvantage #Boston2025 John M., Kevin Leach, Ph.D, DABT, Kelly Brown, Clint H.,
Looking forward to having the Avance Clinical team join us in Boston!